about
Mutations in ERCC4, encoding the DNA-repair endonuclease XPF, cause Fanconi anemiaIn vitro and in vivo susceptibility of mouse megakaryocytic progenitors to strain i of parvovirus minute virus of mice.Direct Conversion of Fibroblasts to Megakaryocyte Progenitors.Intralymphatic Administration of Adipose Mesenchymal Stem Cells Reduces the Severity of Collagen-Induced Experimental Arthritis.Development of an in vitro model for the simultaneous study of the efficacy and hematotoxicity of antileukemic compounds.Biodistribution and Efficacy of Human Adipose-Derived Mesenchymal Stem Cells Following Intranodal Administration in Experimental Colitis.Bcr/Abl interferes with the Fanconi anemia/BRCA pathway: implications in the chromosomal instability of chronic myeloid leukemia cells.Generation of functional neutrophils from a mouse model of X-linked chronic granulomatous disorder using induced pluripotent stem cells.Exploring the link between MORF4L1 and risk of breast cancer.Transforming and tumorigenic activity of JAK2 by fusion to BCR: molecular mechanisms of action of a novel BCR-JAK2 tyrosine-kinase.Conversion of human fibroblasts into monocyte-like progenitor cells.BCR-JAK2 drives a myeloproliferative neoplasm in transplanted mice.Biochemical correction of X-CGD by a novel chimeric promoter regulating high levels of transgene expression in myeloid cells.Origin, functional role, and clinical impact of Fanconi anemia FANCA mutations.Modelling Fanconi anemia pathogenesis and therapeutics using integration-free patient-derived iPSCsStem cell gene therapy for fanconi anemia: report from the 1st international Fanconi anemia gene therapy working group meeting.Parvovirus infection suppresses long-term repopulating hematopoietic stem cellsEpigenetic Alterations in Fanconi Anaemia: Role in Pathophysiology and Therapeutic Potential.Generation of a High Number of Healthy Erythroid Cells from Gene-Edited Pyruvate Kinase Deficiency Patient-Specific Induced Pluripotent Stem Cells.Lentiviral Vector-Mediated Correction of a Mouse Model of Leukocyte Adhesion Deficiency Type I.Engraftment and in vivo proliferation advantage of gene corrected mobilized CD34(+) cells from Fanconi anemia patients.Lessons Learned from Two Decades of Clinical Trial Experience in Gene Therapy for Fanconi Anemia.Lentiviral-Mediated Gene Therapy in Fanconi Anemia-A Mice Reveals Long-Term Engraftment and Continuous Turnover of Corrected HSCs.Inhibitory effects of marine-derived DNA-binding anti-tumour tetrahydroisoquinolines on the Fanconi anaemia pathway.Correction of SCID-X1 using an enhancerless Vav promoter.A novel lentiviral vector targets gene transfer into human hematopoietic stem cells in marrow from patients with bone marrow failure syndrome and in vivo in humanized mice.Development of lentiviral vectors with optimized transcriptional activity for the gene therapy of patients with Fanconi anemia.Immunoresponse against the transgene limits hematopoietic engraftment of mice transplanted in utero with virally transduced fetal liver.Quantitative PCR analysis reveals a high incidence of large intragenic deletions in the FANCA gene in Spanish Fanconi anemia patients.Use of CFU-GM assay for prediction of human maximum tolerated dose of a new antitumoral drug: Yondelis (ET-743).Mesenchymal stromal cells enhance the engraftment of hematopoietic stem cells in an autologous mouse transplantation model.Jun N-terminal kinase activity and early growth-response factor-1 gene expression are down-regulated in Fanconi anemia group A lymphoblasts.Human Adipose-Derived Mesenchymal Stem Cells Modulate Experimental Autoimmune Arthritis by Modifying Early Adaptive T Cell Responses.Safe and Efficient Gene Therapy for Pyruvate Kinase DeficiencyIn vivo imaging of lung inflammation with neutrophil-specific 68Ga nano-radiotracer.Development of a web course on gene therapy by the international consortium of gene therapy.Gene therapy for Fanconi anemia: one step closer to the clinic.Adipose-derived mesenchymal stromal cells modulate experimental autoimmune arthritis by inducing an early regulatory innate cell signature.Prostaglandin E2 plays a key role in the immunosuppressive properties of adipose and bone marrow tissue-derived mesenchymal stromal cells.Translating the genomics revolution: the need for an international gene therapy consortium for monogenic diseases.
P50
Q28289720-CBFF50E2-60D8-46B0-802C-E3B3B637331BQ33339676-691805BA-7A4D-4119-B3DF-78D73D27CC18Q33435963-C510FD07-7756-4F3F-9608-5ED78BE84F2AQ33586104-286CF440-CDD7-43D0-BC74-EDF4EC8728A1Q33706684-03D6209C-587F-4673-9266-81987197FD55Q33774583-88CBDBAB-66C8-4402-A0F4-8EEAFF747EB7Q33784347-0D78BD76-F2B6-4968-914B-A4C3D14DF429Q33847910-9EC8E096-126B-4DAC-96B6-F48BE8275837Q33863235-FB576108-0775-4C4F-8D35-5420B18B20E6Q34182738-0010A863-7968-4084-9EAB-45B9562F55CAQ34345247-714F0E28-4F9C-4F3C-957C-55FF49FCA468Q34461890-B7B54EA8-C4B1-4F14-A601-EB6DF4246C96Q34473359-6E4C64E3-0C38-49F1-89A6-EE28AF1AF2FAQ34870512-98E1124A-C1A0-4799-B236-22084BE7A9F7Q34918292-C3169118-1621-4F74-80F1-A676191EC62CQ35086128-EBA84C25-68ED-419F-81EC-79716E77B173Q35155102-B42C58B7-8B97-477E-AF1B-9C4E9587D37DQ35806891-B736FF12-E3C2-4998-8EAF-6FBF63A3CA41Q36379316-1B5F9021-9D70-432D-8B43-4944687A33FAQ37280501-03F2D92D-9800-4223-8F03-2705EFA418A9Q38628205-EB3C9520-AA51-44EF-8334-3EB79E613857Q38768398-37FB0EC4-9622-4883-9E73-6E891328E4D3Q38831800-BA10CCCD-5785-4F5E-9A0A-C11A0CC97A60Q39111478-095D245D-D299-4304-9FCF-39A9F22607FDQ39649145-8E0C8A9A-8B24-44C6-B30F-E579119673BCQ39683011-2EE3C403-3231-4437-9D27-D66640C41BFCQ39764994-E4B1B8A6-A077-4BDA-9310-17C4D5B0197AQ39802414-F360AB91-74E4-4FDF-8D47-6ECD97B4E16EQ40508226-F09B9E91-B078-4DBF-9CFB-229D9CE1813BQ40551742-5EA8BEC3-DF8A-419F-B431-DB3498C5D930Q40567182-FF94D730-591C-4E1D-BFB1-1CCEBAC4BAA1Q40637381-7D45A7E7-CA38-475B-8C7F-6F7CAAEC8EE1Q40702107-5CB0E969-49BE-4E12-A2A0-6792CCF34B96Q40772336-5BE5B6BF-4A22-49A6-AB11-E1CFC12B254FQ42379000-AD5D357B-7A28-41F2-B3CD-C49053F805B6Q42422006-CD369F0C-E920-4A0F-B1BA-D5E7431A0E36Q42686916-2A0F6FC4-BED6-4A4E-A026-ED3A6F0486E5Q42763577-7B60F9BD-DC1F-4534-9BDB-26B3D2E5C414Q42922142-31BEAD64-5F4B-477D-8CB5-8C44130A804EQ43232055-E745C943-4809-4BDB-87D1-B196200798DF
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Juan Bueren
@ast
Juan Bueren
@en
Juan Bueren
@es
Juan Bueren
@nl
Juan Bueren
@sl
type
label
Juan Bueren
@ast
Juan Bueren
@en
Juan Bueren
@es
Juan Bueren
@nl
Juan Bueren
@sl
prefLabel
Juan Bueren
@ast
Juan Bueren
@en
Juan Bueren
@es
Juan Bueren
@nl
Juan Bueren
@sl
P1053
L-6112-2014
P106
P21
P31
P3829
P496
0000-0002-3228-7013